Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVJF) Work In Process (2016 - 2018)

Historic Work In Process for Teva Pharmaceutical Industries (TEVJF) over the last 10 years, with Q4 2018 value amounting to $590.0 million.

  • Teva Pharmaceutical Industries' Work In Process fell 117.25% to $590.0 million in Q4 2018 from the same period last year, while for Dec 2018 it was $590.0 million, marking a year-over-year decrease of 117.25%. This contributed to the annual value of $590.0 million for FY2018, which is 117.25% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Work In Process stood at $590.0 million for Q4 2018, which was down 117.25% from $609.0 million recorded in Q3 2018.
  • In the past 5 years, Teva Pharmaceutical Industries' Work In Process ranged from a high of $646.0 million in Q1 2018 and a low of $535.0 million during Q4 2015
  • In the last 5 years, Teva Pharmaceutical Industries' Work In Process had a median value of $601.0 million in 2017 and averaged $594.8 million.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Work In Process plummeted by 1614.42% in 2015, and later surged by 1096.65% in 2017.
  • Teva Pharmaceutical Industries' Work In Process (Quarter) stood at $638.0 million in 2014, then decreased by 16.14% to $535.0 million in 2015, then increased by 0.56% to $538.0 million in 2016, then rose by 10.97% to $597.0 million in 2017, then fell by 1.17% to $590.0 million in 2018.
  • Its Work In Process was $590.0 million in Q4 2018, compared to $609.0 million in Q3 2018 and $605.0 million in Q2 2018.